Conjugates comprising RIPK2 inhibitors
US10781205B2 · kind B2 · utility
1Cited by
8References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 2017 |
| Grant date | Sep 22, 2020 |
| Priority date | — |
| Expiry date | Apr 18, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, for example as inhibitors of the activity of RIP2 kinase, including degrading RIP2 kinase, the treatment of diseases and conditions mediated by the RIP2 kinase, in particular for the treatment of inflammatory diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.